您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (3): 1-4.doi: 10.6040/j.issn.1671-7554.0.2015.1137

• •    下一篇

抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用

孙鹏飞,孟晓,张凯,黎莉   

  1. 山东大学齐鲁医院心内科 教育部和卫生部心血管重构和功能研究重点实验室, 山东 济南 250012
  • 收稿日期:2015-11-20 出版日期:2016-03-10 发布日期:2016-03-10
  • 通讯作者: 黎莉. E-mail lili_8599@163.com E-mail:mail lili_8599@163.com

The effect of resistin-like molecule β on the vulnerability of atherosclerotic plaques in ApoE-/- mice

SUN Pengfei, MENG Xiao, ZHANG Kai, LI Li   

  1. The key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2015-11-20 Online:2016-03-10 Published:2016-03-10

摘要: 目的 探讨抵抗素样分子β(RELMβ)在动脉粥样硬化易损斑块模型中的作用。 方法 60只雄性8周龄ApoE-/-小鼠通过高脂饮食及颈总动脉套管诱导易损斑块形成,进而斑块局部转染慢病毒,根据转染慢病毒的不同随机分为正常对照组、转染携带空载体的慢病毒组(si-NC组)和转染携带干扰序列的慢病毒组(si-RELMβ组),每组20只。继续高脂喂养4周,称重后行安乐死,留取空腹血清及颈总动脉标本。检测血清中血脂含量。采用Western blotting法检测斑块内RELMβ蛋白表达水平。采用天狼猩红及油红O染色分别检测斑块内胶原和脂质含量。采用免疫组化染色法检测斑块内平滑肌细胞、巨噬细胞、白介素-1β(IL-1β)和白介素-6(IL-6)的表达。 结果 3组小鼠体质量及血脂水平无明显差异。si-RELMβ组RELMβ蛋白表达较正常对照组显著降低(P<0.05)。si-RELMβ组斑块内胶原和平滑肌细胞含量较正常对照组显著增加,而脂质和巨噬细胞含量却显著减少,易损指数较正常对照组亦明显降低(P<0.05)。si-RELMβ组炎症因子——IL-1β和IL-6较正常对照组显著减少(P<0.05)。 结论 RELMβ能够促进动脉粥样硬化易损斑块的形成,其机制可能与其促进斑块内炎症因子表达有关。

关键词: 动脉粥样硬化, 抵抗素样分子 β, 白介素-6, 炎症反应, 白介素-1β

Abstract: Objective To explore the effect of resistin-like molecule β(RELMβ)on the vulnerability of atherosclerotic plaques in ApoE-/- mice. Methods A total of 60 male ApoE-/- mice(8 weeks old)were fed with a high-fat diet and a constrictive silastic tube was placed to induce the vulnerable plaques. All mice were divided into 3 groups after surgery(n=20 per group): control, si-NC and si-RELMβ. At the end of week 14, ApoE-/- mice were euthanized to collect the right common carotid arteries and blood from the left ventricle. The contents of total cholesterol, triglycerides, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the blood samples were detected. The protein expressions of RELMβ in all mice were determined with Western blotting. The collagen and lipoid depositions in the plaques were determined with collagen sirius red staining and oil-red O staining, respectively. The contents of macrophages, smooth muscle cells(SMCs), interlenkin-1 beta(IL-1β)and interlenkin-6(IL-6)expressions in the plaques were detected with immunohistochemical methods. Results There were no significant differences in body weight and lipid levels among the 3 groups. Compared with the control group, the si-RELMβ group had significantly decreased RELMβ protein expression, lipid, macrophages, vulnerable index, and expressions of IL-1β and IL-6, increased contents of collagen and SMCs(P<0.05), while those in the si-NC group had no statistical differences. Conclusion RELMβ can increase atherosclerotic plaque instability, and its mechanism is involved with the elevated expressions of IL-1β and IL-6.

Key words: Inflammation, Interlenkin-6, Atherosclerosis, Resistin-like molecule β, Interlenkin-1 beta

中图分类号: 

  • R541.4
[1] Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I[J]. Mayo Clin Proc, 2009, 84(11): 917-938.
[2] Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells(macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability[J]. Am J Pathol, 1996, 149(2): 367-380.
[3] Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis[J]. Eur J Immunol, 2011, 41(9): 2515-2518.
[4] Libby P. Molecular bases of the acute coronary syndromes[J]. Circulation, 1995, 91(11): 2844-2850.
[5] Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes[J]. Nature, 2001, 409(6818): 307-312.
[6] Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules[J]. Proc Natl Acad Sci U S A, 2001, 98(2): 502-506.
[7] Renigunta A, Hild C, Rose F, et al. Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia[J]. FEBS Lett, 2006, 580(3): 900-903.
[8] Kushiyama A, Shojima N, Ogihara T, et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet[J]. J Biol Chem, 2005, 280(51): 42016-42025.
[9] Barnes SL, Vidrich A, Wang ML, et al. Resistin-like molecule beta(RELMbeta/FIZZ2)is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis[J]. J Immunol, 2007, 179(10): 7012-7020.
[10] Fang CL, Yin LJ, Sharma S, et al. Resistin-like molecule-β(RELM-β)targets airways fibroblasts to effect remodelling in asthma: from mouse to man[J]. Clin Exp Allergy, 2015, 45(5): 940-952.
[11] Kushiyama A, Sakoda H, Oue N, et al. Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development[J]. Arterioscler Thromb Vasc Biol, 2013, 33(8): 1986-1993.
[12] Yang JM, Wang Y, Qi LH, et al. Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice[J]. J Cell Mol Med, 2011, 15(3): 602-611.
[13] Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J, 1999, 138(5 Pt 2): 419-420.
[14] Li JJ, Meng X, Si HP, et al. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis[J]. Arterioscler Thromb Vasc Biol, 2012, 32(5): 1158-1166.
[15] Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice[J]. Arterioscler Thromb Vasc Biol, 2003, 23(4): 656-660.
[16] Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996, 94(5): 874-877.
[17] McVay LD, Keilbaugh SA, Wong TM, et al. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis[J]. J Clin Invest, 2006, 116(11): 2914-2923.
[1] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[2] 尹妮,杨关林,姜钧文,王春田,王凤耀,贾连群,高晓宇,潘嘉祥,李芹,李佳,冯元洁,高玉竹,周鹤,张哲. 巴马小型猪冠状动脉粥样硬化模型的评价方法[J]. 山东大学学报(医学版), 2017, 55(7): 1-5.
[3] 张栾,陈欧,栾云,朱晓波,陈元,王一彪. Gemigliptin对野百合碱诱导的肺动脉高压大鼠治疗作用及炎症因子的影响[J]. 山东大学学报(医学版), 2017, 55(5): 19-22.
[4] 张云华,李杰. 颈动脉斑块内新生血管显影程度及血浆Lp-PLA2水平对急性脑梗死的临床诊断价值[J]. 山东大学学报(医学版), 2017, 55(3): 112-116.
[5] 魏丹丹,张澄. 血管紧张素Ⅳ型受体过表达对早期动脉粥样硬化斑块形成的影响[J]. 山东大学学报(医学版), 2016, 54(8): 1-5.
[6] 王丹,亓恒涛,孙书珍. 原发性肾病综合征儿童颈动脉结构和功能改变[J]. 山东大学学报(医学版), 2016, 54(5): 88-91.
[7] 李雪丽,徐丽君. 以孤立性眩晕为首发症状的双侧对称性桥臂梗死1例[J]. 山东大学学报(医学版), 2016, 54(12): 90-92.
[8] 李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 葡萄籽原花青素对小鼠脂肪肝模型缺血再灌注造成的急性肝损伤的保护作用[J]. 山东大学学报(医学版), 2015, 53(9): 41-46.
[9] 王小飞, 王成伟, 王志刚, 丁璇, 王敏卿. 应用Enterprise支架治疗动脉粥样硬化性椎-基底动脉狭窄的探讨[J]. 山东大学学报(医学版), 2015, 53(8): 44-48.
[10] 于昕, 刘晓静, 刘向群. 黄芩苷抑制ox-LDL诱导内皮细胞凋亡的作用[J]. 山东大学学报(医学版), 2015, 53(5): 5-9.
[11] 谭蓓, 关玉庆, 孙慧, 户克庆, 苏国海, 韦敏. 血管内超声检测阿托伐他汀对兔动脉粥样硬化斑块的影响[J]. 山东大学学报(医学版), 2015, 53(5): 10-14.
[12] 段瑞生. 他汀对动脉粥样硬化的免疫调节及其在临床应用中的思考[J]. 山东大学学报(医学版), 2015, 53(5): 1-4.
[13] 于磊, 李振. 白细胞介素33在脑血管病患者血清中的表达及其作用机制[J]. 山东大学学报(医学版), 2015, 53(4): 75-79.
[14] 徐忠阳, 王立启, 徐振兴, 赵乾, 朱世明. RhoA/ROCK信号通路与原发性高血压患者血压变异性及颈动脉内膜中层厚度的相关性[J]. 山东大学学报(医学版), 2015, 53(2): 48-51.
[15] 刘国明, 史浩, 程海超. DCE-MRI在颈动脉粥样硬化斑块新生血管定量测量中的应用[J]. 山东大学学报(医学版), 2015, 53(12): 76-80.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!